MoneyWorks4Me

Aurobindo Pharma board to consider financial results

23 Oct 2012 Evaluate
Aurobindo Pharma has informed that a meeting of the board of directors of the company will be held on November 09, 2012, to consider the un-audited financial results of the company for the quarter and half year ended September 30, 2012 (Q2).

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..